CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.

Abstract

Chemokines play essential roles in the progression of various human cancers; however, the expression and role of CXC chemokines in pancreatic adenocarcinoma (PAAD) have not yet been identified. The aim of this study is to identify the expression patterns, clinical significance and mechanisms of CXC chemokines in regulating tumour microenvironment of PAAD. Three CXC chemokines, including CXCL5, CXCL9, and CXCL10, were significantly overexpressed in PAAD tissues, which were correlated with the poor survival of the patients. CXCL9/10 was associated with change of immune cell pattern in the tumour microenvironment, and supplementation of CXCL9 in the orthotopic murine PAAD model promoted tumour progression. In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines. In vitro treatment of CXCL9 directly led to the suppression of the proliferation, activation, and secretion of anti-tumour cytokines of isolated CD8+ T cells. Inhibition of STAT3 recovered the CXCL9-inhibited proliferation, activation, and secretion of anti-tumour cytokines of CD8+ T cells. Our study indicates CXCL9 as a potential target of immunotherapy in PAAD treatment by regulating the CD8+ T lymphocytes in the tumour microenvironment.

• Authors: Hui-Feng Gao, Chien-Shan Cheng, Jian Tang, Ye Li, Hao Chen, Zhi-Qiang Meng, Zhen Chen, Lian-Yu Chen
• Journal: Aging (Aging (Albany NY)) Vol. 12 Issue 1 Pg. 502-517 (01 08 2020) ISSN: 1945-4589 [Electronic] United States
• PMID: 31913856 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• CXCL9 protein, human
• Chemokine CXCL9
• Recombinant Proteins
• STAT3 Transcription Factor
• STAT3 protein, human

Topics

• Adenocarcinoma (immunology, metabolism, mortality, pathology)
• Animals
• CD8-Positive T-Lymphocytes (drug effects, immunology, metabolism, pathology)
• Cell Line, Tumor
• Chemokine CXCL9 (genetics, metabolism, pharmacology)
• Disease Models, Animal
• Disease Progression
• Gene Expression
• Humans
• Immunomodulation
• Immunophenotyping
• Lymphocyte Activation (drug effects, immunology)
• Lymphocytes, Tumor-Infiltrating (immunology, metabolism, pathology)
• Mice
• Pancreatic Neoplasms (immunology, metabolism, mortality, pathology)
• Prognosis
• Recombinant Proteins (pharmacology)
• STAT3 Transcription Factor (immunology)
• Signal Transduction
• T-Lymphocytes, Cytotoxic (drug effects, immunology, metabolism)
• Tumor Microenvironment (immunology)